Gara Jalqabaatti › Luukemiya Limfoositiikii Keessummaa
Qorannoo klinikaalii Luukemiya Limfoositiikii Keessummaa Ameerikaa Keessatti hirmaatuu
Qorannoo 119 Luukemiya Limfoositiikii Keessummaa f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Boston, MAQorannoo 31
- Columbus, OHQorannoo 28
- Durham, NCQorannoo 27
- Washington, DCQorannoo 22
- Seattle, WAQorannoo 20
- Rochester, MNQorannoo 18
- New York City, NYQorannoo 18
- Houston, TXQorannoo 17
- Baldwin Park, CAQorannoo 16
- Milwaukee, WIQorannoo 15
- Chicago, ILQorannoo 14
- Cincinnati, OHQorannoo 14
- Nashville, TNQorannoo 13
- Jacksonville, FLQorannoo 11
- Atlanta, GAQorannoo 11
- Philadelphia, PAQorannoo 11
- San Diego, CAQorannoo 10
- Kansas City, MOQorannoo 10
- Dallas, TXQorannoo 10
- Portland, ORQorannoo 10
- Pittsburgh, PAQorannoo 10
- Salt Lake City, UTQorannoo 10
- Miami, FLQorannoo 9
- Charlotte, NCQorannoo 9
- Denver, COQorannoo 9
- Tampa, FLQorannoo 8
- St. Louis, MOQorannoo 8
- Los Angeles, CAQorannoo 8
- Cleveland, OHQorannoo 8
- Winston-Salem, NCQorannoo 8
- Des Moines, IAQorannoo 8
- Omaha, NEQorannoo 8
- Queens, NYQorannoo 8
- Minneapolis, MNQorannoo 8
- Cedar Rapids, IAQorannoo 7
- Detroit, MIQorannoo 7
- Billings, MTQorannoo 7
- Fort Wayne, INQorannoo 7
- Aurora, COQorannoo 7
- Clifton, NJQorannoo 7
Naannoon
- AlabamaQorannoo 7
- ArizonaQorannoo 15
- ArkansasQorannoo 4
- CaliforniaQorannoo 32
- ColoradoQorannoo 17
- ConnecticutQorannoo 4
- DelawareQorannoo 4
- Distaarikii KoloombiyaaQorannoo 4
- FloridaQorannoo 34
- GeorgiaQorannoo 16
- IdahoQorannoo 4
- IllinoisQorannoo 17
- IndianaQorannoo 12
- IowaQorannoo 10
- KansasQorannoo 6
- KentuckyQorannoo 7
- LouisianaQorannoo 6
- MaineQorannoo 6
- MarylandQorannoo 23
- MassachusettsQorannoo 33
- MichiganQorannoo 12
- MinnesotaQorannoo 28
- MississippiQorannoo 5
- MissouriQorannoo 13
- MontanaQorannoo 7
- NebraskaQorannoo 8
- NevadaQorannoo 6
- New HampshireQorannoo 3
- New JerseyQorannoo 13
- New MexicoQorannoo 3
- New YorkQorannoo 26
- North CarolinaQorannoo 34
- OhioQorannoo 43
- OklahomaQorannoo 4
- OregonQorannoo 16
- PennsylvaniaQorannoo 22
- Rhode IslandQorannoo 6
- South CarolinaQorannoo 5
- South DakotaQorannoo 3
- TennesseeQorannoo 17
- TexasQorannoo 38
- UtahQorannoo 10
- VirginiaQorannoo 12
- WashingtonQorannoo 26
- WisconsinQorannoo 19
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05006716A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05947851Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06863402Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
Namoota walitti qabaa jiraSadarkaa 1
Hanga umuriin 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT01853631Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07321652Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 110 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05724121Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT03516617A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07582432A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT05645107Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT04269902A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06542250A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06697184A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06846671A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07277231A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06943872A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06973187Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 110 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT00923507Pirtobrutinib for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 75 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07685717Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT03986034A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06136559Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06784167Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT01087333A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07218341Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07648264Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.